The law firm of Kirby McInerney LLP announced today an investigation on behalf of Dentsply Sirona, Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) investors concerning the Company and its officers' possible violations of federal securities laws. On August 9, 2017, the Company disclosed second quarter 2017 earnings that fell below expectations, as well as a SEC investigation, "concerning the Company's accounting and disclosures, including its accounting and disclosures relating to transactions with a significant distributor of the Company." On this news, the Company's stock price fell sharply, $5.18 per share, or 8.44%, to close at $56.23 per share on August 9, 2017. If you purchased or otherwise acquired shares of Dentsply and would like more information pertaining to the investigation, please contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600 or by email at email@example.com to discuss your rights or interests with respect to these matters without any cost to you. Kirby McInerney LLP is a New York-based plaintiffs' law firm concentrating in securities, antitrust, whistleblower and consumer litigation. The firm's efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars, and the firm's achievements and quality of service have been chronicled in numerous published decisions. Additional information about the firm can be found at Kirby McInerney LLP's website: http://www.kmllp.com. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.